The 7 analysts offering 12-month price forecasts for Provention Bio Inc have a median target of 14.00, with a high estimate of 21.00 and a low estimate of 8.00. The median estimate represents a +186.30% increase from the last price of 4.89.
The current consensus among 7 polled investment analysts is to Buy stock in Provention Bio Inc. This rating has held steady since July, when it was unchanged from a Buy rating.Move your mouse over past months for detail
Earnings and Sales Forecasts
Earnings per Share -$0.41
Reporting Date Nov 10
Earnings per Share
Move your mouse over a quarter or year to see how estimates have changed over time.